Iron Horse Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12
Closed -$499 631
2024
Q4
$499 Hold
12
﹤0.01% 463
2024
Q3
$802 Hold
12
﹤0.01% 449
2024
Q2
$1.43K Hold
12
﹤0.01% 385
2024
Q1
$1.28K Hold
12
﹤0.01% 383
2023
Q4
$1.19K Hold
12
﹤0.01% 408
2023
Q3
$1.24K Buy
+12
New +$1.34K ﹤0.01% 409

Other funds holding MRNA

Iron Horse Wealth Management's MRNA Position: Q1 2025 in Review

Iron Horse Wealth Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 12 shares — an estimated $499 sold.

Iron Horse Wealth Management first reported a position in MRNA in Q3 2023 and held it in 6 quarters. The position peaked at $1.43K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Iron Horse Wealth Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Iron Horse Wealth Management sold 12 Moderna shares in Q1 2025, an estimated $499.
  • Iron Horse Wealth Management first reported a position in Moderna in Q3 2023 and held it in 6 quarters.
  • Iron Horse Wealth Management's Moderna position peaked at $1.43K in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Iron Horse Wealth Management's 13F filing for Q1 2025, filed 1 May 2025.